Antibody Dynamics, Seroreversion, and Persistence After Severe Acute Respiratory Syndrome Coronavirus 2: Another Answer

Affiliations

¹ Professor of Medicine and Infectious Diseases, Distinguished Investigator of the Mayo Clinic, Director, Mayo Vaccine Research Group, Mayo Clinic, Rochester, Minnesota, USA.

Gregory A Poland. Clin Infect Dis. 2021.

. 2021 Dec 16;73(12):2163-2165.

doi: 10.1093/cid/ciab243.

¹ Professor of Medicine and Infectious Diseases, Distinguished Investigator of the Mayo Clinic, Director, Mayo Vaccine Research Group, Mayo Clinic, Rochester, Minnesota, USA.

No abstract available

Keywords: COVID-19; antibodies; coronavirus; coronavirus infections; immunity; neutralizing; persistence; spike glycoprotein.

Comment in

Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective Study.
den Hartog G, Vos ERA, van den Hoogen LL, van Boven M, Schepp RM, Smits G, van Vliet J, Woudstra L, Wijmenga-Monsuur AJ, van Hagen CCE, Sanders EAM, de Melker HE, van der Klis FRM, van Binnendijk RS. den Hartog G, et al. Clin Infect Dis. 2021 Dec 16;73(12):2155-2162. doi: 10.1093/cid/ciab172. Clin Infect Dis. 2021. PMID: 33624751 Free PMC article.